Hart, C. and Vogelhuber, M. and Hafner, C. and Landthaler, M. and Berneburg, M. and Haferkamp, S. and Herr, W. and Reichle, A. (2016) Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 30 (11). E119-E121. ISSN 0926-9959, 1468-3083
Full text not available from this repository. (Request a copy)Item Type: | Article |
---|---|
Uncontrolled Keywords: | ; |
Subjects: | 600 Technology > 610 Medical sciences Medicine |
Divisions: | Medicine > Lehrstuhl für Dermatologie und Venerologie Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) |
Depositing User: | Dr. Gernot Deinzer |
Date Deposited: | 22 Mar 2019 11:11 |
Last Modified: | 22 Mar 2019 11:11 |
URI: | https://pred.uni-regensburg.de/id/eprint/4051 |
Actions (login required)
![]() |
View Item |